Repository logo
 

Myeloid progenitor cluster formation drives emergency and leukaemic myelopoiesis

Accepted version
Peer-reviewed

Type

Article

Change log

Authors

Hérault, A 
Binnewies, M 
Leong, S 
Calero-Nieto, FJ 
Zhang, SY 

Abstract

Although many aspects of blood production are well understood, the spatial organization of myeloid differentiation in the bone marrow remains unknown. Here we use imaging to track granulocyte/macrophage progenitor (GMP) behaviour in mice during emergency and leukaemic myelopoiesis. In the steady state, we find individual GMPs scattered throughout the bone marrow. During regeneration, we observe expanding GMP patches forming defined GMP clusters, which, in turn, locally differentiate into granulocytes. The timed release of important bone marrow niche signals (SCF, IL-1β, G-CSF, TGFβ and CXCL4) and activation of an inducible Irf8 and β-catenin progenitor self-renewal network control the transient formation of regenerating GMP clusters. In leukaemia, we show that GMP clusters are constantly produced owing to persistent activation of the self-renewal network and a lack of termination cytokines that normally restore haematopoietic stem-cell quiescence. Our results uncover a previously unrecognized dynamic behaviour of GMPs in situ, which tunes emergency myelopoiesis and is hijacked in leukaemia.

Description

Keywords

Animals, Cell Self Renewal, Cellular Reprogramming, Cytokines, Granulocyte-Macrophage Progenitor Cells, Granulocytes, Interferon Regulatory Factors, Leukemia, Macrophages, Mice, Molecular Imaging, Myelopoiesis, Neoplastic Stem Cells, Stem Cell Niche, beta Catenin

Journal Title

Nature

Conference Name

Journal ISSN

0028-0836
1476-4687

Volume Title

544

Publisher

Nature Publishing Group
Sponsorship
Cancer Research UK (21762)
Leukaemia & Lymphoma Research (12029)
Medical Research Council (MC_PC_12009)
Medical Research Council (MR/M008975/1)
This work was supported by NIH K01DK098315 award to E.M.P.; a Bloodwise and CRUK program grants and Wellcome Trust funding to the Cambridge Stem Cell Institute to B.G.; and NIH R01HL092471, R01HL111266 and P30DK063720 grants, Rita Allen Scholar Award and Leukemia Lymphoma Society Scholar Award to E.P.